Trial
NCT05974527
Pilot Study 1: Efficacy and Safety of Sublingual Dexmedetomidine (BXCL501) for the Treatment of Agitation in the Emergency Department
Phase IVWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Brigham and Women's Hospital
Collaborators
—
Condition
Agitation
Intervention
Sublingual film containing dexmedetomidine (BXCL501)
Why stopped
Study did not start - due to funding issues prior to IRB approval
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-01-28